|
Charles Conrad, M.D., serves as Tyrell’s chief medical
officer. In this role, he has been instrumental in directing the
application of Zeno ä . His medical and microbiological background
has proved to be invaluable in the developmental stages of Zeno
technology. He has helped design and implement both preclinical
and clinical testing of the Zeno concept and device.
Dr. Conrad earned his B.S. in microbiology from Texas A&M
University and went on
to study medicine at the
University of Texas Medical
School at Houston . He is an associate professor in the Department
of Neuro-Oncology, Division of Cancer Medicine at the University
of Texas M. D. Anderson Cancer Center in Houston , Texas.
The recipient of numerous honors, awards and grants, he has
served as the principal
investigator or co-investigator
on nearly 70 protocols. He has 16 patents filed or pending and
has been published over 70 times.
Dr. Conrad’s professional memberships include Society
for Neuro-Oncology, American Medical Association, American Academy
of Neurology, Kansas City Neurology and Neurosurgery Society,
Kansas City Round Table of Hematology/Oncology, North American
Brain Tumor Consortium, American Association for Cancer Research
and American Society of Clinical Oncology.
Out of the office, he enjoys spending time with his wife and
three children as well as playing golf, reading and rebuilding
project cars.
 Zeno
Press Kit
Be sure to visit us in
the near future for updates,
news, and the latest on
Zeno.
For all media inquiries,
please contact Allison
M. Allison at Richards/Gravelle,
214-891-5212 or allison_allison@richards.com.
|
